IL1B and Alzheimer disease: We selected cytokine Interleukin-1β (IL-1β), which is known to initiate inflammatory responses [53] and reported to be elevated in brains of AD patients [54] to analyze whether vitamin D3 and vitamin D2 analogues might reduce inflammatory responses and used ELISA technique to determine IL-1β level.